Evidence map›Paper›PMID 24958424›Full record

ArticleNeurogenetics2014

AIMP1 deficiency presents as a cortical neurodegenerative disease with infantile onset.

L Armstrong, R Biancheri, C Shyr, A Rossi, G Sinclair, C J Ross, M Tarailo-Graovac, W W Wasserman, C D M van Karnebeek

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Neurogenetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Child neurology open · 2019
    Article
  10. Article
  11. Article
  12. Exome Sequencing and the Management of Neurometabolic Disorders.The New England journal of medicine · 2016
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

L ArmstrongTreatable Intellectual Disability Endeavour in British Columbia, Vancouver, Canada.
R Biancheri
C Shyr
A Rossi
G Sinclair
C J Ross
M Tarailo-Graovac
W W Wasserman
C D M van Karnebeek

Funding

Canadian Institutes of Health Research 301221
6 · The paper itself

Abstract

We report the second family with AIMP1 deficiency, due to a homozygous truncating AIMP1 (g.107248613 C > T) mutation. This female showed early-onset developmental arrest, intractable epileptic spasms, microcephaly, and a rapid clinical course leading to premature death, associated with cerebral atrophy and myelin deficiency on brain MRI. Clinical and neuroimaging findings are consistent with a primary neuronal degenerative disorder, rather than with the previously reported Perlizaeus-Merzbacher-like phenotype. Given its critical role in neurofilament assembly 16, impaired myelin formation is due to neuronal/axonal dysfunction. We propose that AIMP1 deficiency be added to the differential diagnosis of infantile onset, progressive neurodegenerative disease.

Indexed as

Age FactorsBrainCytokinesFemaleHumansInfant, NewbornMutationNeoplasm ProteinsNeurodegenerative DiseasesRNA-Binding ProteinsWhite MatterCytokinesNeoplasm ProteinsRNA-Binding Proteinssmall inducible cytokine subfamily E, member 1

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.